Brain WMH
Overview
Quantib Brain WMH, now integrated into DeepHealth’s Neuro Suite, is an FDA-cleared artificial intelligence (AI) software designed to support radiologists in interpreting brain MRI scans. It provides automatic labeling, visualization, and volumetric quantification of segmentable brain structures and white matter hyperintensities (WMH) from magnetic resonance (MR) images. The tool measures brain atrophy and detects WMH, which are critical neuroimaging features related to aging, dementia, and multiple sclerosis. It offers automatic atrophy analysis and longitudinal WMH analyses, distinguishing between new and previously identified WMHs. The output includes segmentations, visualizations, and volumetric measurements of grey matter, white matter, and cerebrospinal fluid, which can be compared to reference centile data. The software is deployed through the Quantib AI Node platform, enabling efficient workflow integration and web browser access to results.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automatic labeling, visualization, and volumetric quantification of brain structures
- Detection and quantification of white matter hyperintensities (WMH)
- Automatic atrophy analysis and longitudinal atrophy analysis
- Longitudinal WMH analyses, distinguishing new and previously identified WMHs
- Comparison of volumetric measurements to reference centile data
- Easy review and editing of WMH segmentation in an internet browser
- Clear overviews of quantitative results in a report per analysis
- Segmentations in DICOM secondary capture format
- Color-coded anatomical overlays on T1 images and standard PACS viewers
- Comprehensive reports integrating quantified measurements and segmentation results
Use Cases
- Support radiologists in interpreting brain MRI scans
- Measures brain atrophy and detects white-matter hyperintensities
- Provides insight into atrophy related to Alzheimer's disease or other types of dementia
- Tracking of neurodegeneration over time
- Monitoring of Multiple Sclerosis (MS) patients
- Aid in quantitative reporting for trained medical professionals
What Physicians Need to Know
Leverage the quantitative measurements for objective assessment and consistent follow-up in neurodegenerative disease management. Utilize the longitudinal analysis feature to track subtle changes in brain atrophy and WMH progression over time. Always review and, if necessary, edit the automated WMH segmentations before final validation to ensure accuracy in quantitative reporting. Integrate the comprehensive reports into multidisciplinary team communications for enhanced patient care.
The tool integrates via AI marketplaces or distribution platforms, and can also function as a standalone third-party application. It provides output in formats such as segmentation overlays and draft radiology reports, including DICOM secondary capture format for segmentations, enabling seamless PACS integration for immediate visual assessment.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing — Subscription-based; tiers typically based on number of installations and users. |
| Deployment | On-premise (locally on dedicated hardware) via Quantib AI Node platform, with web browser access |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Yes AI-estimated FDA 510(k) cleared (K251527) for Brain WMH. It is a non-invasive medical imaging processing application intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and white matter hyperintensities from MR images. It aids trained medical professionals in the evaluation and assessment of MR brain images and quantitative reporting for patients 22 years or older, without pathologies (e.g., tumor or stroke), treatment-induced features, and without contrast enhancement. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Radiology |
What the Web Says
Quantib Brain WMH is an FDA-cleared and CE-marked AI-powered software designed to automatically label, visualize, and volumetrically quantify white matter hyperintensities (WMHs) from T2-weighted FLAIR MR images. It aims to assist trained medical professionals in evaluating and assessing MR brain images and aid in quantitative reporting, especially for conditions related to aging, dementia, and multiple sclerosis. The software provides segmentations and volumetric measurements of WMHs, and its newer versions also offer automatic longitudinal atrophy and WMH analyses.
Overall: PositiveStrengths
- Automated segmentation and volumetric quantification of WMHs, streamlining clinical workflow.
- Aids in quantitative reporting and evaluation of brain MR images for conditions like dementia and multiple sclerosis.
- Offers longitudinal analysis for tracking WMH progression over time.
- Validated for accuracy against manual segmentations on diverse datasets.
- FDA-cleared and CE-marked, indicating regulatory compliance and safety.
- Can operate as a plug-in for GE Advantage Workstation, integrating into existing radiology environments.
Limitations
- Requires user review and validation of WMH segmentations before reporting.
- Older versions of Quantib Brain required both FLAIR and T1 scans, though newer versions only need T2 FLAIR.
- Diagnostic agreement between different software packages for normative brain volumetry can be moderate.
- While WMH are associated with cognitive decline, the exact relationship and efficacy of interventions targeting WMH reduction still require further research.
Based on reviews from: RadAI Slice, AuntMinnie, SourceForge, PubMed, FDA.report, X-ray Interpreter
Last updated: 2026-07-19
Ratings & Reviews
Rate Brain WMH
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Brain WMH.
